Raltitrexed (Tomudex™) plus doxorubicin (DOX) in patients with advanced gastric cancer:: Interim results of a phase I dose escalation study

被引：0
|
作者：
Bjarnason, G [1 ]
Charpentier, D [1 ]
Winquist, E [1 ]
Wong, R [1 ]
Matthews, S [1 ]
Seymour, L [1 ]
机构：
[1] NCI, Canada Clin Trials Grp, Kingston, ON, Canada
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
459
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Raltitrexed (Tomudex™) concomitant with radiotherapy as adjuvant treatment for patients with rectal cancer:: Preliminary results of phase I studies
    James, R
    Price, P
    Valentini, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S19 - S22
  • [22] Raltitrexed (Tomudex™) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer:: Preliminary results from phase I clinical trials
    Schwartz, GK
    Harstrick, A
    Barón, MG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S9 - S13
  • [23] A Phase I study of 'Tomudex' and gemcitabine in advanced cancer
    Cripps, C
    Batist, G
    Dahrouge, S
    Fry, D
    McQuillan, A
    Kolendowicz, R
    Abugaber, AA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S289 - S289
  • [24] Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer
    Marshall, John
    Shapiro, Geoffrey I.
    Uttenreuther-Fischer, Martina
    Ould-Kaci, Mahmoud
    Stopfer, Peter
    Gordon, Michael S.
    FUTURE ONCOLOGY, 2013, 9 (02) : 271 - 281
  • [25] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    R D Kim
    S R Alberts
    C Peña
    I Genvresse
    A Ajavon-Hartmann
    C Xia
    A Kelly
    J E Grilley-Olson
    British Journal of Cancer, 2018, 118 : 462 - 470
  • [26] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    Kim, R. D.
    Alberts, S. R.
    Pena, C.
    Genvresse, I.
    Ajavon-Hartmann, A.
    Xia, C.
    Kelly, A.
    Grilley-Olson, J. E.
    BRITISH JOURNAL OF CANCER, 2018, 118 (04) : 462 - 470
  • [27] Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
    Bayet-Robert, Mathilde
    Kwiatkowski, Fabrice
    Leheurteur, Marianne
    Gachon, Francoise
    Planchat, Eloise
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Durando, Xavier
    Barthomeuf, Chantal
    Chollet, Philippe
    CANCER BIOLOGY & THERAPY, 2010, 9 (01) : 8 - 14
  • [28] Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer
    Fizazi, K
    Ducreux, M
    Ruffié, P
    Bonnay, M
    Daniel, C
    Soria, JC
    Hill, C
    Fandi, A
    Poterre, M
    Smith, M
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2293 - 2300
  • [29] A pharmacodynamic study of raltitrexed (Tomudex®) in patients with advanced colorectal cancer:: Predictors of response and toxicity
    Ford, HER
    Farrugia, DC
    Cunningham, D
    McVicar, D
    McCarthy, K
    Mitchell, F
    Aherne, GW
    Jackman, AL
    Danenberg, K
    Lenz, HJ
    Danenberg, PV
    ANNALS OF ONCOLOGY, 1998, 9 : 158 - 158
  • [30] Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx®) in combination with topotecan in patients with advanced malignancies
    Ghesquieres, Herve
    Faivre, Sandrine
    Djafari, Latifa
    Pautier, Patricia
    Lhomme, Catherine
    Lozahic, Stephanie
    Djazouli, Kamel
    Armand, Jean-Pierre
    Raymond, Eric
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) : 413 - 421
12345